Assessing fetal radiation dose from iodine-125 seeds in pregnant breast cancer patients: an updated model
Open Access
- 29 January 2025
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (3) , 035010
Abstract
Objective. The treatment of breast cancer during pregnancy requires careful consideration of consequences for both maternal and fetal health. In non-pregnant patients, the use of radioactive iodine-125 (125I)-seeds is standard practice for localising non-palpable breast tumors before breast-conserving surgery. However, the use of 125I-seeds in pregnant patients has been avoided due to concerns about fetal radiation exposure. Approach. In this study a mathematical model was developed to estimate the fetal absorbed dose based on several factors: the radioactivity of the 125I-seed, the duration of implantation, and the distance between the 125I-seed and fetus as a function of maternal anatomy, gestational age, and fetal development. Three scenarios, representing a range of maternal and fetal anatomy, were evaluated, including a worst-case scenario from a radiation safety perspective. Main results. The results show that the fetal absorbed dose varies across the three scenarios, with ranges of 0.0–0.4 mGy, 0.0–1.0 mGy, and 0.0–1.6 mGy, depending on when the 125I-seed was implanted and when it was removed. These dose ranges are similar to conventional diagnostic x-ray scans. The maximum calculated absorbed dose (1.6 mGy) is unlikely to be reached in practice and is well below the 100 mGy threshold associated with possible fetal malformations. The associated theoretical cancer risk increase (0.016%) is minimal. Significance. The use of 125I-seeds as localisation method of breast tumors in pregnant patients results in low fetal radiation doses and should not be avoided due to dose concerns.Keywords
This publication has 48 references indexed in Scilit:
- Fetal dose assessment in a pregnant patient with brain tumor: A comparative study of proton PBS and 3DCRT/VMAT radiation therapy techniquesJournal of Applied Clinical Medical Physics, 2024
- Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controlsEuropean Journal of Cancer, 2022
- Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalitiesBest Practice & Research Clinical Obstetrics & Gynaecology, 2022
- Breast cancer‐specific survival by clinical subtype after 7 years follow‐up of young and elderly women in a nationwide cohortInternational Journal of Cancer, 2018
- A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation StudyClinical Breast Cancer, 2017
- Development of computational pregnant female and fetus models and assessment of radiation dose from positron-emitting tracersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Locoregional treatment of breast cancer during pregnancyGynecological Surgery, 2014
- Breast cancer in pregnancy: Recommendations of an international consensus meetingEuropean Journal of Cancer, 2010
- Breast carcinoma during pregnancyCancer, 2005
- Randomized Prospective Evaluation of a Novel Technique for Biopsy or Lumpectomy of Nonpalpable Breast Lesions: Radioactive Seed Versus Wire LocalizationAnnals of Surgical Oncology, 2001